HF1399 (Legislative Session 94 (2025-2026))

Commissioner of corrections required to maintain a supply of opiate antagonists to administer to persons who overdose in correctional facilities, and commissioner required to provide training to employees on how to administer opiate antagonists.

Related bill: SF2837

AI Generated Summary

This bill requires the Minnesota Commissioner of Corrections to maintain a supply of opiate antagonists, such as naloxone, in all correctional facilities to respond to opioid overdoses. It mandates that these medications be stored in multiple locations within each facility to ensure rapid access. Additionally, the commissioner, in consultation with the Commissioner of Health, must provide training for correctional employees on recognizing overdose symptoms and administering nasal opiate antagonists. The bill aims to improve overdose response and inmate safety within correctional facilities.

Bill text versions

Actions

DateChamberWhereTypeNameCommittee Name
February 23, 2025HouseFloorActionIntroduction and first reading, referred toPublic Safety Finance and Policy
February 25, 2025HouseFloorActionAuthor added
March 04, 2025HouseFloorActionAuthors added

Citations

 
[
  {
    "analysis": {
      "added": [
        "Includes a definition requirement for opiate antagonists as used in correctional facilities."
      ],
      "removed": [],
      "summary": "References the definition of opiate antagonists under section 604A.04.",
      "modified": []
    },
    "citation": "604A.04"
  },
  {
    "analysis": {
      "added": [
        "Clarifies administration procedures for opiate antagonists."
      ],
      "removed": [],
      "summary": "Specifies compliance requirements for administration of opiate antagonists under section 151.37.",
      "modified": []
    },
    "citation": "151.37"
  }
]